Wilson Wai-Shun Cheung

This profile gathers the share dealings of Wilson Wai-Shun Cheung across 2 companies, led by Sciclone Pharmaceuticals Inc and AXT Inc. Over a trading history stretching from 6 March 2008 to 13 October 2017, the count stands at 51 filings.

On the open market, the record shows 1 purchase worth €988 and 20 sales worth €2.2M. Taken together, the sales exceed the purchases by €2.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 8 share grants and 21 option exercises. 2017 to date brings no purchases and 3 sales.

The latest filing, published on 16 October 2017, reports a share grant in Sciclone Pharmaceuticals Inc. The clock since the last published purchase (10 November 2008) now reads 6,556 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.